↓ Skip to main content

Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial

Overview of attention for article published in Circulation, November 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
9 news outlets
policy
2 policy sources
twitter
144 X users
patent
3 patents
facebook
3 Facebook pages

Citations

dimensions_citation
257 Dimensions

Readers on

mendeley
319 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
Published in
Circulation, November 2019
DOI 10.1161/circulationaha.119.044138
Pubmed ID
Authors

Mikhail N Kosiborod, Pardeep S Jhund, Kieran F Docherty, Mirta Diez, Mark C Petrie, Subodh Verma, Jose C Nicolau, Béla Merkely, Masafumi Kitakaze, David L DeMets, Silvio E Inzucchi, Lars Køber, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Scott D Solomon, Olof Bengtsson, Daniel Lindholm, Anna Niklasson, Mikaela Sjöstrand, Anna Maria Langkilde, John J V McMurray

X Demographics

X Demographics

The data shown below were collected from the profiles of 144 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 319 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 319 100%

Demographic breakdown

Readers by professional status Count As %
Other 31 10%
Researcher 25 8%
Student > Master 25 8%
Student > Doctoral Student 24 8%
Student > Bachelor 22 7%
Other 50 16%
Unknown 142 45%
Readers by discipline Count As %
Medicine and Dentistry 111 35%
Pharmacology, Toxicology and Pharmaceutical Science 12 4%
Nursing and Health Professions 11 3%
Biochemistry, Genetics and Molecular Biology 11 3%
Agricultural and Biological Sciences 4 1%
Other 23 7%
Unknown 147 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 153. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2024.
All research outputs
#274,232
of 25,839,971 outputs
Outputs from Circulation
#774
of 21,284 outputs
Outputs of similar age
#6,310
of 478,924 outputs
Outputs of similar age from Circulation
#14
of 147 outputs
Altmetric has tracked 25,839,971 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 21,284 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 478,924 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 147 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.